| Typicality: | 0.473 |
| Saliency: | 0.522 |
| currently | 15 | temporal |
| in over 50 countries | 8 | location |
| under the brand name | 7 | manner |
| drug → be approved in → europe | 105 |
| drug → be approved in → the eu | 16 |
| drug → be approved in → the european union | 12 |
| drug → be approved in → eu | 10 |
| drug → be approved for → the european union | 5 |
| drug → be approved in → european countries | 3 |
| negative | neutral | positive |
| 0.094 | 0.504 | 0.402 |
| Raw frequency | 151 |
| Normalized frequency | 0.522 |
| Modifier score | 0.500 |
| Perplexity | 56.532 |